Not applicableStudy completedNCT04322474What this trial is testingRussian National Registry of LAAOWho this might be right forAtrial Fibrillation National Research Center for Preventive Medicine 200
Large-scale testing (Phase 3)Ended earlyNCT05643573What this trial is testingLearn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for StrokeWho this might be right forPrevention of Stroke or Systemic EmbolismAtrial Fibrillation Bayer 14,830
Not applicableUnknownNCT02028130What this trial is testingLeft Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation: A Safety and Feasibility StudyWho this might be right forPersistent Atrial Fibrillation Royal Brompton & Harefield NHS Foundation Trust 20
Not applicableStudy completedNCT02468102What this trial is testingStudy of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)Who this might be right forAcute Coronary SyndromeVenous ThrombosisPulmonary Embolism+1 more Bayer 99,999
Large-scale testing (Phase 3)Study completedNCT00403767What this trial is testingAn Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationWho this might be right forAtrial FibrillationStrokeEmbolism Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269
Not applicableStudy completedNCT04356989What this trial is testingStudy to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal FunctionWho this might be right forNon-valvular Atrial Fibrillation (NVAF) Bayer 493
Not applicableUnknownNCT03327350What this trial is testingWATCHMAN for Second Prevention of Stroke (WASPS)Who this might be right forAtrial FibrillationStroke Second Affiliated Hospital, School of Medicine, Zhejiang University 400
Not applicableStudy completedNCT01871194What this trial is testingAn Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).Who this might be right forAtrial FibrillationDeep Vein ThrombosisPulmonary Embolism Professor Saad Shakir 3,400
Not applicableActive Not RecruitingNCT07194811What this trial is testingStroke of Unknown Cause in Women: The Impact of Long-term Heart Monitoring on Stroke RecurrenceWho this might be right forCryptogenic StrokeAtrial FibrillationImplantable Cardiac Monitor+4 more University Hospital, Akershus 1,400
Not applicableStudy completedNCT00861354What this trial is testingHome Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure MonitorWho this might be right forAtrial Fibrillation Microlife 150
Not applicableStudy completedNCT04233515What this trial is testingUse of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro CountyWho this might be right forAtrial FibrillationStroke, Ischemic Region Örebro County 11,964
Not applicableNot Yet RecruitingNCT07598903What this trial is testingPharmacy-based Opportunistic Atrial Fibrillation Screening Integrated With Emergency Services (NUMAPLUS-FA)Who this might be right forAtrial Fibrillation (Prevention of Stroke)Arrythmia, CardiacMass Screening+1 more Centro de Emergencias Sanitarias 061 Andalucía 380
Not applicableStudy completedNCT03746301What this trial is testingXarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial FibrillationWho this might be right forNon-valvular Atrial Fibrillation (NVAF) Bayer 924
Large-scale testing (Phase 3)Study completedNCT03273322What this trial is testingAssessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage ClosureWho this might be right forAtrial FibrillationAtrial AppendageHemorrhage Assistance Publique - Hôpitaux de Paris 105
Not applicableStudy completedNCT02640222What this trial is testingAPIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM StudyWho this might be right forAnticoagulation Bristol-Myers Squibb 321,501
Not applicableUnknownNCT02743416What this trial is testingSystematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP IIWho this might be right forAtrial FibrillationStroke Karolinska University Hospital 6,868
Post-approval studies (Phase 4)Study completedNCT01288352What this trial is testingEarly Treatment of Atrial Fibrillation for Stroke Prevention TrialWho this might be right forAtrial FibrillationStroke Atrial Fibrillation Network 2,789
Not applicableStudy completedNCT03887780What this trial is testingEvaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)Who this might be right forNon-valvular Atrial Fibrillation (NVAF) Bayer 504
Not applicableStudy completedNCT03572972What this trial is testingNon-interventional, Retrospective Cohort Study to Explore OAC Treatment in KoreaWho this might be right forAtrial Fibrillation Pfizer 64,684
Not applicableStudy completedNCT02181361What this trial is testingHirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial FibrillationWho this might be right forCardioembolic StrokeAtrial Fibrillation Xijing Hospital 239